14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SNYR vs AHG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Synergy CHC Corp. (SNYR) is the stronger overall head-to-head candidate over Akso Health Group ADS (AHG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, R&D & Supply-Chain Moat). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas AHG carries 38.2/100 (SELL) at $1.26 (N/M Forward P/E, -28.9% operating margin).
Growth vs. Quality Trade-Off: SNYR earns the overall head-to-head edge with a stronger Unified Composite Score (48.9/100 HOLD vs. AHG 38.2/100 SELL) and -0.86β · 868% Vol risk profile, whereas AHG leads top-line expansion (-12.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNYR vs AHG. Trailing 12-month operating profitability (SNYR -10.3% vs AHG -28.9%) and valuation multiples (SNYR 0.6x vs AHG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Distribution value chain with $1.1B market capitalization and -28.9% operating margin.
OpEx & R&D Reinvestment28.8% of Rev ($4.0M)
90D Engineering Disclosures0 Published
Investor FAQ SNYR vs AHG Key Questions & Quantitative Answers
As of Nov 20, 2026, Synergy CHC Corp. (SNYR) is the stronger overall head-to-head candidate over Akso Health Group ADS (AHG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, R&D & Supply-Chain Moat). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas AHG carries 38.2/100 (SELL) at $1.26 (N/M Forward P/E, -28.9% operating margin). Growth vs. Quality Trade-Off: SNYR earns the overall head-to-head edge with a stronger Unified Composite Score (48.9/100 HOLD vs. AHG 38.2/100 SELL) and -0.86β · 868% Vol risk profile, whereas AHG leads top-line expansion (-12.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
AHG leads the Growth & Scale pillar: SNYR posts -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin), compared with AHG at -12.9% YoY revenue growth and +0.0% YoY earnings growth on $14M TTM revenue (-0.1% gross margin, -28.9% operating margin). On trailing 12-month operating scale, SNYR generates $28M in USD-normalized revenue versus $14M for AHG. In operating R&D and SG&A reinvestment, SNYR deploys 75.7% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 28.8% of Rev ($4.0M) (0 disclosures) for AHG.
SNYR screens cheaper on headline valuation multiples. SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin), whereas AHG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 79.3x EV/Revenue (-11.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNYR (-361.1% ROE) versus AHG (-9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk). By comparison, AHG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 101% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.